Robin Shattock is a Professor of Mucosal Infection and Immunity at Imperial College, London. The main focus of his research is the investigation of the mechanisms of mucosal infection and development of novel preventative strategies. His group has a strong interest in mucosal immune responses to infection and vaccination with active programs on COVID-19, HIV, Ebola, Lassa, Marburg and Chlamydia. Prof Shattock has secured funding from the MRC-UK, EPSRC, CEPI and European Commission. He is the scientific director of the European AIDS Vaccine Initiative (EAVI2020) that coordinates a program of EU funded vaccine research across 22 institutions. He directs the Future Vaccines Manufacturing Research Hub and Imperial College. His research team is leading a range of clinical trials of candidate vaccines. Prof. Shattock Chairs the Research and Advisory Steering Committee of the International Partnership for Microbicides. He is the Founder of VacEquity Global Health and VaxEquity Ltd. His is an elected fellow of the Academy of Medical Sciences.